The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Rapidly adapting the clinical research environment at an NCI-designated comprehensive cancer center to the COVID-19 pandemic.
 
Andrew B. Lassman
Consulting or Advisory Role - Bayer; BioClinica; Chimerix; Elsevier; Karyopharm Therapeutics; Novocure; Orbus Therapeutics; Sapience Therapeutics; Vivacitas Oncology
Research Funding - Abbvie (Inst); Aeterna Zentaris (Inst); Bayer (Inst); BeiGene (Inst); BMS (Inst); Chimerix (Inst); Corden (Inst); DelMar Pharmaceuticals (Inst); Genentech/Roche (Inst); Kadmon (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Millennium (Inst); NextSource (Inst); Novartis (Inst); Novocure (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); QED Therapeutics (Inst); Semus (Inst); Servier (Inst); VBI Vaccines (Inst)
Travel, Accommodations, Expenses - Chimerix; Karyopharm Therapeutics; Novartis; Novocure; Orbus Therapeutics; Pfizer; QED Therapeutics; VBI Vaccines
 
Frances L. Brogan
No Relationships to Disclose
 
Ryan J. Shelton
Stock and Other Ownership Interests - Shockwave Medical
 
Edward Bentlyewski
Research Funding - Genentech/Roche (Inst)
 
Moshe A. Kelsen
Research Funding - Pfizer (Inst)
 
Helen Kim
No Relationships to Disclose
 
Brenda L. Ruotolo
No Relationships to Disclose
 
Anil K. Rustgi
No Relationships to Disclose
 
Joseph G. Jurcic
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Jazz Pharmaceuticals; Novartis; Syros Pharmaceuticals
Research Funding - Abbvie (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb/Celgene (Inst); Celularity (Inst); FORMA Therapeutics (Inst); Gilead/Forty Seven (Inst); GlycoMimetics (Inst); PTC Therapeutics (Inst); Syros Pharmaceuticals (Inst)
(OPTIONAL) Uncompensated Relationships - Actinium Pharmaceuticals